or
Bookmark and Share
Pharmaceutical and cosmetic compositions containing as an active ingredient 1,8-dihydroxy-10-phenyl-9-anthrone and a process for preparation thereof
   
Document Number
US Patent 4677123
Issued Date
June 30, 1987
Link
Inventors
Lang; Gerard (Epinay-sur-Seine,FR)
Maignan; Jean (Tremblay les Gonesse,FR)
Map
Abstract
Pharmaceutical or cosmetic composition containing as the active component 1,8-dihydroxy-10-phenyl-9-anthrone, and a process for preparing said active component.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
2
Comments:
no comments yet
Published
June 30, 1987
Application Number
06/753,906
Filed
July 11, 1985
US Classification
514/680  
Int'l Classification
C07C   49/737   (20060101)   C07C   49/00   (20060101)  
Attorney/Law Firm
Priority Data
Jul 12, 1984 [FR] 84 11075
USPTO Field of Search
514/680  
Related Patents
7238377 - Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity - Owned by Laboratoires Expanscience (Courbevoie,FR)

The invention concerns the use of at least an oil derived from the seeds of the gourd family selected from the group consisting of Lagenaria, Luffa and Momordica, for preparing a composition designed to inhibit 5.alpha.-reductase activity, and the use of said oil for preparing a composition for treating prostatic hypertrophy, prostatic adenoma, acne, hyperseborrhea, alopecia, and hirsutism. The invention also concerns cosmetic treatment methods, in particular for greasy skin. The invention further concerns the use of at least an oil derived from seeds of the gourd family in a nutritional food composition for humans and/or animals as additive for inhibiting 5.alpha. reductase activity.

5844004 - 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals - Owned by Teva Pharmaceutical Industries, Ltd. (Petah-Tiqva,IL)

Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.

5661187 - 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals - Owned by Teva Pharmaceutical Industries, Ltd. (Petah Tiqva,IL)

Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.

5426197 - 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals - Owned by Teva Pharmaceutical Industries, Ltd. (Petah Tiqva,IL)

Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.

4843097 - 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics - Owned by Groupement d'Interet Economique dit: Centre International de Recherches (Valbonne,FR)

Mono, di and tri-esters of 1,8-dihydroxy-10-phenyl-9-anthrone or -9-anthranol have the formula ##STR1## wherein p is 0 or 1, (a) when p=0, t=1 and R.sub.2 represents hydrogen or --COR.sub.3, (b) when p=1, t=0 and R.sub.1 and R.sub.2 each independently represent hydrogen or --COR.sub.3, R.sub.3 represents linear or branched alkyl having 1-17 carbon atoms, cycloalkyl, phenyl or phenyl substituted by lower alkyl, lower alkoxy, halogen, a nitro function, --CF.sub.3 or a hydroxyl function, and mixtures of said esters. These esters are prepared by reacting 1,8-dihydroxy-10-phenyl-9-anthrone with an activated form of an acid. The esters are useful in human or veterinary medicine and in cosmetic compositions.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us